| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |